Cross-Trial Comparison Don'ts

22/08/2024 19 min
Cross-Trial Comparison Don'ts

Listen "Cross-Trial Comparison Don'ts"

Episode Synopsis

We all know we aren't supposed to make cross-trial comparisons, but it happens anyway. So, let's compare FLARUA2 (osimertinb + chemo) and the newly FDA-approved MARIPOSA regimen (lazertinib + amivantamab) to see what we can (and can't) take away from such a dangerous cross-trial comparison.